Bersabe, Mildred M.

HRN: 09-34-71  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2022
CEFUROXIME 1.5GM (VIAL)
08/18/2022
08/18/2022
IV
1.5gm
On Call To OR
Prophylaxis For Completion Curettage
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: